Kahibah, Australia

Kylie Jane Ralston

USPTO Granted Patents = 2 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Kylie Jane Ralston and Her Contributions to Chaperonin Research

Introduction: Kylie Jane Ralston is a renowned inventor based in Kahibah, Australia. With a passion for biotechnology, she has made significant contributions to the field, particularly in the area of chaperonin proteins. Ralston is credited with two patents that reflect her innovative approach to solving complex biological problems.

Latest Patents: Ralston's latest patents include "Modified Cpn10" and "Chaperonin 10 Variants." The "Modified Cpn10" patent focuses on isolated Cpn10 polypeptides that demonstrate an increased affinity for a PRR ligand compared to the standard Ala Cpn10 polypeptide. This invention not only encompasses modified chaperonin 10 polypeptides but also includes nucleic acids encoding these polypeptides and related compositions. The "Chaperonin 10 Variants" patent emphasizes N-terminal variants of chaperonin 10 that possess enhanced immunomodulatory capacity and improved binding affinity for pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs).

Career Highlights: Kylie Jane Ralston has carved a niche for herself in the biotech industry through her work with Cbio Limited. Her research primarily revolves around protein interactions and their implications for immune responses, making her a key player in biomedical innovation. Her inventive spirit and dedication to scientific advancement have garnered attention and respect within the research community.

Collaborations: Throughout her career, Ralston has collaborated with esteemed colleagues, including Dean Jason Naylor and Richard James Brown. These collaborations have not only enriched her research endeavors but have also fostered a culture of innovation within her work environment.

Conclusion: Kylie Jane Ralston exemplifies the spirit of innovation in the field of biotechnology. With her groundbreaking patents and collaborative efforts, she continues to contribute to the understanding of chaperonin proteins and their potential applications in medicine. Her work serves as an inspiration for aspiring inventors and scientists in Australia and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…